FDA Dietary Supplement Claims Oversight Will Be “More Aggressive” – Troy
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to intensify enforcement of inappropriate structure/function claims, Chief Counsel Daniel Troy asserted at the Food & Drug Law Institute educational conference April 16-17
You may also be interested in...
CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?
CFSAN will begin sending letters to companies notifying them when an adverse event report involving one of their products has been received on or after Sept. 16
CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?
CFSAN will begin sending letters to companies notifying them when an adverse event report involving one of their products has been received on or after Sept. 16
CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?
CFSAN will begin sending letters to companies notifying them when an adverse event report involving one of their products has been received on or after Sept. 16